Lee Ainslie - Maverick Capital
Holding/activity history for Atara Biotherapeutics Inc. (ATRA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 0 | 0 | Sell 100.00% | 0.22 | |
| 2023 Q3 | 251,628 | 0.22 | $37.00 | ||
| 2023 Q2 | 251,628 | 0.22 | $40.25 | ||
| 2023 Q1 | 251,628 | 0.47 | Reduce 0.00% | 0.00 | $72.50 |
| 2022 Q4 | 251,640 | 0.50 | Reduce 19.92% | 0.12 | $82.00 |
| 2022 Q3 | 314,232 | 0.67 | $94.50 | ||
| 2022 Q2 | 314,232 | 1.53 | $194.75 | ||
| 2022 Q1 | 314,232 | 1.31 | $232.25 | ||
| 2021 Q4 | 314,232 | 1.50 | $394.00 | ||
| 2021 Q3 | 314,232 | 1.55 | Add 1.96% | 0.03 | $447.50 |
| 2021 Q2 | 308,187 | 1.13 | Add 14.32% | 0.14 | $388.75 |
| 2021 Q1 | 269,576 | 0.91 | Reduce 7.99% | 0.08 | $359.00 |
| 2020 Q4 | 292,981 | 2.30 | Add 8.57% | 0.18 | $490.75 |
| 2020 Q3 | 269,851 | 1.63 | Reduce 0.12% | 0.00 | $324.00 |
| 2020 Q2 | 270,164 | 2.07 | Add 29.89% | 0.48 | $364.25 |
| 2020 Q1 | 207,995 | 0.93 | Add 4.87% | 0.04 | $212.75 |
| 2019 Q4 | 198,337 | 1.19 | Reduce 2.85% | 0.03 | $411.75 |
| 2019 Q3 | 204,158 | 1.06 | Add 128.62% | 0.60 | $353.00 |
| 2019 Q2 | 89,299 | 0.65 | Add 156.38% | 0.40 | $502.75 |
| 2019 Q1 | 34,830 | 0.46 | Buy | 0.46 | $993.77 |